Posted by Michael Wonder on 31 Jul 2022
Schedule of Pharmaceutical Benefits - 1 August 2022
1 August 2022 - The August 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The August issue of the Schedule includes a few new/revised listings:
- Diroximel fumarate - new medicine
- Infliximab (Remsima SC) - restriction change
- Paliperidone palmitate (Invega Hafyera) - new formulation
- Nusinersen sodium (Spinraza) - new indication
